XHKG
1262
Market cap41mUSD
Feb 13, Last price
1.50HKD
Name
Labixiaoxin Snacks Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Labixiaoxin Snacks Group Limited, an investment holding entity, specializes in the production and sale of a diverse array of snack items within the People's Republic of China. Its extensive product portfolio includes various types of jellies, such as fruit-flavored, canned fruit, yogurt, and mousse jellies, alongside jelly-based drinks. The company also offers a selection of confectioneries like lollipops, milk and gummy candies, and chocolates. Additionally, it produces fruit and vegetable beverages, powdered milk tea, dried bean curd, and baked goods. These products are marketed under well-known brands including Labixiaoxin, Sunshine City, Humor, and Xiangdoufang. Established in 2000 and headquartered in Jinjiang, China, the company was previously known as China Lifestyle Food and Beverages Group Limited before adopting its current name in June 2012. Labixiaoxin Snacks Group Limited operates as a subsidiary of Alliance Food and Beverages (Holding) Company Limited.
Key people
Yu Huan Zheng
Executive Chairman of the Board · since 2015
Hung Kong Li
Non-Executive Vice Chairman of the Board · since 2011
Yee Lok Chan
Chief Financial Officer, Company Secretary · since 2014
Yu Long Zheng
Executive Director · since 2015
Yu Shuang Zheng
Chief Executive Officer, Executive Director · since 2011
Xi Lian
Director of Sales, Director of Marketing · since 2014
Jian Ming Chen
Head of Procurement Department
Head of Corporate Finance · since 2014
Xiao Dong Zhang
Head of Research and Development and Quality control Department
Non-Executive Director · since 2015
Yau Tong Chung
Independent Non-Executive Director · since 2011
Zhi Hai Li
Independent Non-Executive Director · since 2011
Kam Ching Sun
Independent Non-Executive Director · since 2011
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||